Biden Official Says Marijuana Will Likely to be Rescheduled Before the 2024 Election

An official with the Biden Administration tells us it’s their belief that marijuana will be moved to schedule III prior to the 2024 election.

In a letter sent recently to the Drug Enforcement Agency (DEA), the Department of Health (DOH) officially requested that marijuana to be reclassified as a Schedule III drug under the Controlled Substances Act. This would effectively legalize it for prescription use, with other schedule III drugs including codeine, ketamine and testosterone. The letter comes in response to an executive order issued last year by President Biden asking Health Secretary Xavier Becerra and Attorney General Merrick Garland to initiate a review process to consider marijuana rescheduling.

Currently marijuana is classified as a Schedule I drug, putting it alongside hard drugs such as heroin and LSD and indicating that it has “no known medical benefit”. This makes it illegal for all purposes under all circumstances.

The Biden Administration official, who asked to remain anonymous but who’s credentials we were able to independently verify, says that it’s the Administration’s belief that the entire process of rescheduling marijuana will be completed prior to the November, 2024 election.

“Yes, that’s what we are anticipating and hoping for.”

The official says this move will “show the world that we’re serious about marijuana reform.”

The official says that although President Biden does not support legalizing recreational marijuana or descheduling it altogether, “he’s getting there” as his views progress.

According to two separate polls released earlier this year, 64% of adults in the United States support marijuana being legalized for recreational use.

Thank you for reading The Marijuana Herald! You can find more news stories by clicking here, and you can signup for our newsletter by clicking here

 

 

More articles from The Marijuana Herald.

Florida Lawmaker Files Bill to Ban Public Marijuana Smoking Across the State

Florida Lawmaker Files Bill to Ban Public Marijuana Smoking Across the State

Massachusetts Cannabis Regulators Expected to Finalize Long-Delayed Social Consumption Rules by Christmas

Massachusetts Cannabis Regulators Expected to Finalize Long-Delayed Social Consumption Rules by Christmas

Curaleaf Appeals $31.8 Million Judgment in Michigan Contract Fight With Hello Farms

Curaleaf Appeals $31.8 Million Judgment in Michigan Contract Fight With Hello Farms

Arizona Marijuana Tax Revenue Reached $20.7 Million in October, $233.2 Million Year-to-Date in 2025

Arizona Marijuana Tax Revenue Reached $20.7 Million in October, $233.2 Million Year-to-Date in 2025

New Jersey Bill Would Expand Dispensary Access, Loosen CRC Restrictions, and Strengthen Enforcement Against Illegal Operators

New Jersey Bill Would Expand Dispensary Access, Loosen CRC Restrictions, and Strengthen Enforcement Against Illegal Operators

THC Strengthens Brain-Based Pain Filtering in Fibromyalgia, New Clinical Trial Finds

THC Strengthens Brain-Based Pain Filtering in Fibromyalgia, New Clinical Trial Finds

Hemp Shows Strong Antiviral Activity Against Japanese Encephalitis Virus

Hemp Shows Strong Antiviral Activity Against Japanese Encephalitis Virus

Higher Light Intensity During Flowering Found to Boost CBD Production in Hemp

Higher Light Intensity During Flowering Found to Boost CBD Production in Hemp

Psilocybin Shows Potential to Improve Long-Term Effects of Repetitive Brain Injuries Linked to Intimate Partner Violence

Psilocybin Shows Potential to Improve Long-Term Effects of Repetitive Brain Injuries Linked to Intimate Partner Violence

Florida Campaign to Legalize Recreational Cannabis Has Submitted 675,000 Verified Signatures for 2026 Initiative

Florida Campaign to Legalize Recreational Cannabis Has Submitted 675,000 Verified Signatures for 2026 Initiative

Ohio Marijuana Market Generated $1.25 Billion in Sales Since Adult-Use Launch in August 2024, Producing $164 Million in Tax Revenue

Ohio Marijuana Market Generated $1.25 Billion in Sales Since Adult-Use Launch in August 2024, Producing $164 Million in Tax Revenue

Study: Medical-Grade THC Vape Delivers Precise Microdoses, While Retail Pens Hit Hard but With Unstable Output

Study: Medical-Grade THC Vape Delivers Precise Microdoses, While Retail Pens Hit Hard but With Unstable Output

Arkansas Medical Marijuana Program Reaches 112,760 Registered Patients

Arkansas Medical Marijuana Program Reaches 112,760 Registered Patients

New Mexico Marijuana Sales Reach $475 Million in 2025, Nearly $2 Billion All-Time

New Mexico Marijuana Sales Reach $475 Million in 2025, Nearly $2 Billion All-Time

Curaleaf Reports $320 Million in Q3 Revenue, 158 Dispensaries Across the U.S.

Curaleaf Reports $320 Million in Q3 Revenue, 158 Dispensaries Across the U.S.

Aurora Cannabis Reports $90.4 Million in Fiscal Q2 2026 Revenue, Driven by Record Medical Sales

Aurora Cannabis Reports $90.4 Million in Fiscal Q2 2026 Revenue, Driven by Record Medical Sales

Trulieve Reports $288 Million in Q3 Revenue and $173 Million Year-to-Date Free Cash Flow

Trulieve Reports $288 Million in Q3 Revenue and $173 Million Year-to-Date Free Cash Flow

Study: CBD Shown to Suppress Growth Pathways in Aggressive Breast Cancer Cells

Study: CBD Shown to Suppress Growth Pathways in Aggressive Breast Cancer Cells